This means doctors deliberately reduce your body's ability to fight off infections or diseases. They might do this using special medicines or sometimes by removing certain types of immune cells. The goal is to stop your body from attacking your own tissues, like in an organ transplant.
Every report comes from a Lived member, sent anonymously.
Have you tried Immunosuppression Therapy for Aplastic Anemia?
Immunosuppression therapy uses medicines that deliberately turn down the immune system. Its most common use is after an organ transplant. The immune system recognizes a donated kidney, liver, heart or lung as foreign and, left unchecked, attacks it, a process called rejection. Anti-rejection medicines keep that attack from taking hold. A similar approach is used in some autoimmune diseases, where the immune system damages the body's own tissues. Transplant care usually combines several medicines that act on the immune response in different ways. A common pairing is tacrolimus (Prograf), which blocks a chemical signal immune cells need to switch on, and mycophenolate (CellCept), which keeps immune cells from multiplying, often along with a corticosteroid (steroid) that broadly reduces inflammation. The trade-off is built into the treatment: the same dampening that protects the organ also weakens defenses against infection and some cancers. The aim is enough suppression to prevent rejection, and no more than that.
Anyone who receives a solid organ transplant, such as a kidney, liver, heart or lung, needs anti-rejection medicine for as long as the organ is working, which in practice usually means for the rest of their life. Doses and target blood levels are generally highest in the first months after surgery and lowered once the new organ is settled. Immunosuppressive medicines are also used for autoimmune and inflammatory diseases, such as rheumatoid arthritis, when the immune system is attacking the body itself. In that setting the choice of medicine, the dose and the length of treatment depend on the disease, and some conditions need long-term treatment while others do not. This page focuses mainly on transplant care, where the approach is most standardized.
Anti-rejection medicines start around the time of transplant surgery and continue as daily pills at home. Before leaving the hospital, people learn what each medicine is for and when to take it. Tacrolimus is taken at the same times every day (twice daily, 12 hours apart, for the standard capsules) and consistently either with or without food, because timing and meals change how much of the drug reaches the blood. Other medicines, such as antibiotics to prevent certain infections, are often added for a period after surgery. Regular blood tests are central to the treatment. The team measures the level of drugs such as tacrolimus in the blood, typically just before a dose, and adjusts the dose to keep it within a target range. A level that is too low raises the risk of rejection; one that is too high raises the risk of side effects such as kidney damage. The same tests track kidney and liver function, blood sugar and other markers. Tacrolimus comes as twice-daily capsules and as once-daily extended-release products (Envarsus XR, Astagraf XL). These forms are not interchangeable, so any switch should happen only under the transplant team's direction, and a refill that looks different from usual is worth confirming with the team or pharmacist before taking it.
Most people take several medicines a day, and the schedule becomes a fixed part of daily life. Taking every dose on time matters more than with many medicines. In studies of kidney transplant recipients, missed doses were common and were linked to a much higher chance of losing the transplanted kidney, and large swings in tacrolimus blood levels were associated with more rejection. Reminders and routines help some people, although studies of reminder apps have not clearly shown that they improve adherence. Rejection often begins before a person feels any different, which is why routine blood tests matter. In a kidney transplant it may eventually show up as rising blood pressure or swelling. When tests show early signs, the team usually responds by adjusting medicines. Rejection can still happen even when every dose is taken as prescribed. Side effects vary from person to person. Tacrolimus can cause tremor, headache and stomach upset. Some anti-rejection medicines change appearance, with a fuller face, weight gain, acne or extra facial hair, though not everyone has these effects. Follow-up visits and blood tests continue for as long as the medicines are taken.
Anti-rejection medicine itself is not in question for transplant recipients: without it, the immune system attacks the new organ. Research instead compares combinations, doses and their side effects. For kidney transplants, an analysis of 30 randomized trials found that tacrolimus prevented more acute rejection and more graft loss in the first year than cyclosporine, an older medicine from the same family. For every 100 people treated with tacrolimus instead of cyclosporine, about 12 avoided an episode of acute rejection and 2 avoided losing the kidney, but about 5 more developed diabetes needing insulin. The authors concluded that the best choice may differ between people. For liver transplants, a Cochrane review found no clear difference in survival or graft loss among the main maintenance combinations, but the trials were of low quality. Transplant guidelines similarly note a lack of definitive long-term outcome trials, so many choices rest on clinical judgment about an individual's risks. For autoimmune diseases, the evidence is specific to each condition and each medicine.
Because these medicines weaken the immune system, infections are more likely and can be serious, sometimes leading to hospitalization or death. They include ordinary infections, unusual ones that rarely affect healthy people, and reactivation of viruses carried from the past. The medicines can also blunt symptoms, so a problem may be more serious than it looks. Call the transplant team right away for a fever over 100°F, chills or sweats, burning when urinating, a cold or cough that won't go away, a warm, red, painful area of skin, or simply feeling unwell. Live vaccines should be avoided during treatment, and other vaccines may work less well, so vaccinations are best planned with the team. Over years, immunosuppression raises the risk of some cancers, particularly skin cancer and lymphoma (a cancer of immune cells). The risk depends on how strong and how long the immunosuppression is more than on which drug is used. Protective clothing, broad-spectrum sunscreen and regular skin checks are standard advice. Individual medicines carry their own effects. Tacrolimus and cyclosporine can damage the kidneys, raise blood pressure and cause diabetes, so blood sugar, kidney function and blood pressure are monitored; frequent urination or unusual thirst is worth reporting. Some anti-rejection medicines also contribute to cataracts, bone disease and extra stomach acid over time. Interactions are an everyday concern. Grapefruit and grapefruit juice raise tacrolimus levels and should be avoided, and many prescription drugs, over-the-counter products, herbal remedies and supplements can push levels up or down. Tell the transplant team and pharmacist before starting or stopping anything. Mycophenolate can cause miscarriage and birth defects. People who could become pregnant need counseling on contraception and pregnancy planning, and anyone hoping to become pregnant should raise it with the team well in advance, since a safer alternative may be needed. Tacrolimus can also affect a developing pregnancy. The medicines are expensive and needed long-term. Transplant social workers can help with insurance and drug-company assistance programs.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Immunosuppression Therapy, what's helped you, or ask the community a question.